Read More 5 minute read Pharma Industry News Can Avacta’s peptide drug conjugates rival ADCs? The next chapter in targeted cancer delivery Avacta’s peptide drug conjugates could change how we deliver cancer drugs. Find out how they compare to ADCs and what’s next for the UK biotech’s platform. byPallavi MadhirajuSeptember 5, 2025